A. Galitzia

Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine

G. Angioni, G. Caocci, G. la Nasa, 2022, Vaccines.

Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

A. Frustaci, M. Deodato, G. Zamprogna, 2022, Therapeutic advances in hematology.

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

K. Stamatopoulos, D. Lad, T. Chatzikonstantinou, 2023, EClinicalMedicine.

Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis

G. Caocci, R. Murru, A. Galitzia, 2024, Annals of hematology.